Now the excitement has died down, perhaps people are starting to think about the likely time frames involved here, even just to get to human trials will probably be well beyond Melrose's lifetime!
Then maybe revenue to come - but first - huge, massive capital injection will be needed.
As posted in the past, this is likely to be an excellent trading stock - and so far that is spot on!
Good luck to all
Cabe
Ann: Lead compound reduces illness in mice infected by E.coli, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
0.003(0.69%) |
Mkt cap ! $104.8M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 39.5¢ | 36.0¢ | $72.04K | 191.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46885 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 1245 | 1 |
View Market Depth
| Last trade - 15.58pm 23/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |